Nektar Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Nektar Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 2% to $90,122,000. The net income raised on -$276,056,000 and profit margin reached -306%. Total operating expenses were $190,903,000.
Profit Margin
| 2014 | 200.70M | -53.91M | -26.86% |
|---|---|---|---|
| 2015 | 230.78M | -81.17M | -35.17% |
| 2016 | 165.43M | -153.52M | -92.8% |
| 2017 | 307.71M | -96.69M | -31.42% |
| 2018 | 1.19B | 681.31M | 57.09% |
| 2019 | 114.61M | -440.66M | -384.47% |
| 2020 | 152.91M | -444.44M | -290.65% |
| 2021 | 101.90M | -523.83M | -514.03% |
| 2022 | 92.05M | -368.19M | -399.98% |
| 2023 | 90.12M | -276.05M | -306.31% |
NKTR Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 90.12M | 92.05M | 101.90M | 152.91M | 114.61M | 1.19B | 307.71M | 165.43M | 230.78M | 200.70M |
Cost of revenue | 36.64M | 21.63M | 24.89M | 19.47M | 21.37M | 24.41M | 30.54M | 30.21M | 34.10M | 28.53M |
Gross profit | 53.47M | 70.42M | 77.01M | 133.43M | 93.24M | 1.16B | 277.16M | 135.22M | 196.68M | 172.17M |
Operating exp. | ||||||||||
Research and development | 114.16M | 218.32M | 400.26M | 408.67M | 434.56M | 399.53M | 268.46M | 203.80M | 182.78M | 147.73M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 190.90M | 310.65M | 523.11M | 513.36M | 533.27M | 480.97M | 320.82M | 248.07M | 226.05M | 188.65M |
Operating income | -137.42M | -240.23M | -446.10M | -379.92M | -440.03M | 687.93M | -59.64M | -112.85M | -29.37M | -16.48M |
Other income (expenses), net | -138.83M | -124.74M | -77.17M | -64.02M | -19K | -5.20M | -36.43M | -39.79M | -51.3M | -37.94M |
Income before tax | -276.25M | -364.98M | -523.28M | -443.94M | -440.05M | 682.72M | -96.07M | -152.64M | -80.67M | -54.42M |
Income tax expense | -200K | 3.21M | 557K | 493K | 613K | 1.41M | 616K | 876K | 506K | -512K |
Net income | -276.05M | -368.19M | -523.83M | -444.44M | -440.66M | 681.31M | -96.69M | -153.52M | -81.17M | -53.91M |
Earnings per share | ||||||||||
Basic EPS | -1.45 | -1.97 | -2.86 | -2.49 | -2.52 | 3.78 | -0.62 | -1.1 | -0.61 | -0.42 |
Diluted EPS | -1.45 | -1.97 | -2.86 | -2.49 | -2.52 | 3.78 | -0.62 | -1.1 | -0.61 | -0.42 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |